UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.117

Sortiert nach

The human homologue of macaque area V6A

NeuroImage (Orlando, Fla.), 2013-11, Vol.82, p.517-530

2013

Volltextzugriff (PDF)

Hypoalbuminemia in COVID‐19: assessing the hypothesis for underlying pulmonary capillary leakage

Journal of internal medicine, 2021-06, Vol.289 (6), p.861-872

2021

Volltextzugriff (PDF)

Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO)

British journal of cancer, 2006-11, Vol.95 (9), p.1155-1160

2006

Volltextzugriff (PDF)

Hospital reengineering against COVID-19 outbreak: 1-month experience of an Italian tertiary care center

European review for medical and pharmacological sciences, 2020-08, Vol.24 (15), p.8202

2020

Volltextzugriff (PDF)

Assessing storm surge risk under future sea-level rise scenarios: a case study in the North Adriatic coast

Journal of coastal conservation, 2017-08, Vol.21 (4), p.453-471

2017

Volltextzugriff (PDF)

Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)

Cancer chemotherapy and pharmacology, 2009-09, Vol.64 (4), p.769-775, Article 769

2009

Volltextzugriff (PDF)

Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)

British journal of cancer, 2007-04, Vol.96 (7), p.1047-1051

2007

Volltextzugriff (PDF)

New Strategies for Treatment of Sepsis

2021

Volltextzugriff (PDF)

Human Rickettsia aeschlimannii infection: first case with acute hepatitis and review of the literature

European review for medical and pharmacological sciences, 2016-06, Vol.20 (12), p.2630

2016

Volltextzugriff (PDF)

PO-134: Retrospective analysis of treatment outcomes of sinonasal malignancies. Our 22-year experience

Radiotherapy and oncology, 2017-03, Vol.122, p.64-65

2017

Volltextzugriff (PDF)

Manufacturing Refused Knowledge in the Age of Epistemic Pluralism: Discourses, Imaginaries, and Practices on the Border of Science

1, 2024

Volltextzugriff (PDF)

The role of treatments in IDH mutant molecular astrocytomas

Annals of oncology, 2017-10, Vol.28, p.vi76-vi76

2017

Volltextzugriff (PDF)

Primary Cutaneous Coccidioidomycosis in an Italian Nun Working in South America and Review of Published Literature

Mycopathologia (1975), 2015-10, Vol.180 (3-4), p.229-235

2015

Volltextzugriff (PDF)

IDH mutant and 1p19q codeleted low grade gliomas: to treat or not to treat?

Annals of oncology, 2017-10, Vol.28, p.vi75-vi75

2017

Volltextzugriff (PDF)

The role of clinical and molecular characteristics in low grade gliomas

Annals of oncology, 2017-10, Vol.28, p.vi75-vi76

2017

Volltextzugriff (PDF)

Innovation Capacity and the City: The Enabling Role of Design

1, 2018

Volltextzugriff (PDF)

Temozolomide three weeks on and one week off as first line therapy for patients with recurrent or progressive low grade gliomas

Journal of neuro-oncology, 2008-09, Vol.89 (2), p.179-185

2008

Volltextzugriff (PDF)

How effective is BCNU in recurrent glioblastoma in the modern era? A phase II trial

Neurology, 2004-10, Vol.63 (7), p.1281

2004

Volltextzugriff (PDF)

A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated

European journal of cancer (1990), 2001-11, Vol.37 (17), p.2178-2183

2001

Volltextzugriff (PDF)

Gender and MGMT methylation in glioblastoma patients: interactions in the PERNO prospective study

Annals of oncology, 2017-10, Vol.28, p.vi75-vi75

2017

Volltextzugriff (PDF)

Sagopilone (ZK-EPO, ZK 219477) for recurrent glioblastoma. A phase II multicenter trial by the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor Group

Annals of oncology, 2011-09, Vol.22 (9), p.2144-2149

2011

Volltextzugriff (PDF)

2924 Time to response (TTR) and early tumor shrinkage (ETS) in recurrent glioblastoma patients treated with bevacizumab: An exploratory analysis of the prospective randomized AVAREG (ML25739) phase II study

European journal of cancer (1990), 2015-09, Vol.51, p.S592-S592

2015

Volltextzugriff (PDF)

Salvage PCV chemotherapy for temozolomide-resistant oligodendrogliomas

Neurology, 2004-09, Vol.63 (5), p.904

2004

Volltextzugriff (PDF)

MATILDE regimen followed by radiotherapy is an active strategy against primary CNS lymphomas

Neurology, 2006-05, Vol.66 (9), p.1435

2006

Volltextzugriff (PDF)

Setting the conditions for efficient, robust and reproducible generation of functionally active neurons from adult subventricular zone-derived neural stem cells

Cell death and differentiation, 2008-12, Vol.15 (12), p.1847-1856

2008

Volltextzugriff (PDF)

1 – 25 von 1.117

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(940)
Mit Volltextzugriff
(994)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(562)
Life Sciences & Biomedicine
(402)
Humans
(365)
Female
(185)
Male
(177)
Adult
(141)
Middle Aged
(125)
Physical Sciences
(118)
Biological And Medical Sciences
(102)
Oncology
(102)
Aged
(100)
Chemistry
(92)
Technology
(89)
Medical Sciences
(83)
Chemistry, Physical
(69)
Science & Technology - Other Topics
(57)
Materials Science
(56)
Tumors
(55)
Physics
(52)
Animals
(51)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(37)
Journal Of Physical Chemistry. C
(36)
Annals Of Oncology
(19)
Digestive And Liver Disease
(17)
Apuntes
(14)
Plos One
(12)
Problemas Del Desarrollo
(12)
Scientific Reports
(11)
Cancer
(9)
European Journal Of Cancer Supplements
(9)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

The human homologue of macaque area V6A

Hypoalbuminemia in COVID‐19: assessing the hypothesis for underlying pulmonary capillary leakage

Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO)

Hospital reengineering against COVID-19 outbreak: 1-month experience of an Italian tertiary care center

Assessing storm surge risk under future sea-level rise scenarios: a case study in the North Adriatic coast

Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)

Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)

New Strategies for Treatment of Sepsis

Human Rickettsia aeschlimannii infection: first case with acute hepatitis and review of the literature

PO-134: Retrospective analysis of treatment outcomes of sinonasal malignancies. Our 22-year experience

Manufacturing Refused Knowledge in the Age of Epistemic Pluralism: Discourses, Imaginaries, and Practices on the Border of Science

The role of treatments in IDH mutant molecular astrocytomas

Primary Cutaneous Coccidioidomycosis in an Italian Nun Working in South America and Review of Published Literature

IDH mutant and 1p19q codeleted low grade gliomas: to treat or not to treat?

The role of clinical and molecular characteristics in low grade gliomas

Innovation Capacity and the City: The Enabling Role of Design

Temozolomide three weeks on and one week off as first line therapy for patients with recurrent or progressive low grade gliomas

How effective is BCNU in recurrent glioblastoma in the modern era? A phase II trial

A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated

Gender and MGMT methylation in glioblastoma patients: interactions in the PERNO prospective study

Sagopilone (ZK-EPO, ZK 219477) for recurrent glioblastoma. A phase II multicenter trial by the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor Group

2924 Time to response (TTR) and early tumor shrinkage (ETS) in recurrent glioblastoma patients treated with bevacizumab: An exploratory analysis of the prospective randomized AVAREG (ML25739) phase II study

Salvage PCV chemotherapy for temozolomide-resistant oligodendrogliomas

MATILDE regimen followed by radiotherapy is an active strategy against primary CNS lymphomas

Setting the conditions for efficient, robust and reproducible generation of functionally active neurons from adult subventricular zone-derived neural stem cells

Suchergebnisse filtern